Literature DB >> 31736274

Bugs, Drugs, and Shrugs.

James T Rosenbaum1, Lisa Karstens2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31736274      PMCID： PMC7113093          DOI： 10.1002/art.41166

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  21 in total

1.  Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.

Authors:  Wolfgang Hueber; Bruce E Sands; Steve Lewitzky; Marc Vandemeulebroecke; Walter Reinisch; Peter D R Higgins; Jan Wehkamp; Brian G Feagan; Michael D Yao; Marek Karczewski; Jacek Karczewski; Nicole Pezous; Stephan Bek; Gerard Bruin; Bjoern Mellgard; Claudia Berger; Marco Londei; Arthur P Bertolino; Gervais Tougas; Simon P L Travis
Journal:  Gut       Date:  2012-05-17       Impact factor: 23.059

Review 2.  Gut microbiota modulation of chemotherapy efficacy and toxicity.

Authors:  James L Alexander; Ian D Wilson; Julian Teare; Julian R Marchesi; Jeremy K Nicholson; James M Kinross
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-08       Impact factor: 46.802

Review 3.  IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans.

Authors:  Heather R Conti; Sarah L Gaffen
Journal:  J Immunol       Date:  2015-08-01       Impact factor: 5.422

4.  Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells.

Authors:  Hsin-Jung Wu; Ivaylo I Ivanov; Jaime Darce; Kimie Hattori; Tatsuichiro Shima; Yoshinori Umesaki; Dan R Littman; Christophe Benoist; Diane Mathis
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

5.  Secukinumab failure in Crohn's disease: the yeast connection?

Authors:  Jean Frédéric Colombel; Boualem Sendid; Thierry Jouault; Daniel Poulain
Journal:  Gut       Date:  2012-12-11       Impact factor: 23.059

6.  A defined commensal consortium elicits CD8 T cells and anti-cancer immunity.

Authors:  Takeshi Tanoue; Satoru Morita; Damian R Plichta; Ashwin N Skelly; Wataru Suda; Yuki Sugiura; Seiko Narushima; Hera Vlamakis; Iori Motoo; Kayoko Sugita; Atsushi Shiota; Kozue Takeshita; Keiko Yasuma-Mitobe; Dieter Riethmacher; Tsuneyasu Kaisho; Jason M Norman; Daniel Mucida; Makoto Suematsu; Tomonori Yaguchi; Vanni Bucci; Takashi Inoue; Yutaka Kawakami; Bernat Olle; Bruce Roberts; Masahira Hattori; Ramnik J Xavier; Koji Atarashi; Kenya Honda
Journal:  Nature       Date:  2019-01-23       Impact factor: 49.962

7.  Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism.

Authors:  T Andrew Clayton; David Baker; John C Lindon; Jeremy R Everett; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

8.  IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.

Authors:  Liang Zhou; Ivaylo I Ivanov; Rosanne Spolski; Roy Min; Kevin Shenderov; Takeshi Egawa; David E Levy; Warren J Leonard; Dan R Littman
Journal:  Nat Immunol       Date:  2007-06-20       Impact factor: 25.606

9.  Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine.

Authors:  Ivaylo I Ivanov; Rosa de Llanos Frutos; Nicolas Manel; Keiji Yoshinaga; Daniel B Rifkin; R Balfour Sartor; B Brett Finlay; Dan R Littman
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

10.  Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation.

Authors:  Alice Valentin-Torres; Carine Savarin; Joslyn Barnett; Cornelia C Bergmann
Journal:  J Neuroinflammation       Date:  2018-04-24       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.